Abstract
Since 1908, since exactly 75 years ago, the usage of the term “group of schizophrenias” suggested by Eugen BLEULER for the endogenous psychoses for whose central group Emil KRAEPELIN coined the term “dementia praecox” in the 6th edition of his textbook in 1899, has become standard in psychiatry.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Literature
M. Ackenheil, D. Athen, H. Beckmann: Pathophysiology of delirious states. J of Neural Transmission, Suppl. 14, 167–175 (1978)
M. Ackenheil, H. Hippius, N. Matussek: Ergebnisse der biochemischen Forschung auf dem Schizophreniegebit. Der Nervenarzt 49, 634–649 (1978)
M. Ackenheil, R. Engel: Stressuntersuchungen bei psychiatrischen Patienten. 75-Jahrfeier der Psychiatrischen Klinik der Universitäte München. Münchener Med Wschr, 123, No 19, 805–808 (1981)
M. Ackenheil: Biochemical effects of apomorphine: contribution to schizophrenia research: apomorphine and other dopaminomimetics, VI 2, Clinical Pharmacol, 215–225, Raven Press N.W. Eds.: G. U. Corsini, G.L. Gessa (1981)
M. Ackenheil, U. Münch, H. Wissmann: Die Bedeutung des Mienenspiels in der Psychiatrie. 99. Wander Versammlung süd westdeutscher Psychiater und Neurologen Baden-Baden, 1983.
M. Albus, M. Ackenheil, U. Münche, D. Naber: Ceruletide: A new drug for the treatment of schizophrenic patients? Arch Gen Psychiatry, Vol 4, 528 (1984)
M. Ansseau, A. Doumont, 3.3. Legros: Evidence for two subgroups of schizophrenics with regard to dopaminergic sensitivity. 5th CA Symposium Göteborg 1983. Abstracts. Suppl to Progress in Neuro-Psychopharmacology and Biological Psychiatry, p 69
B. Bondy, M. Ackenheil, R. Elbers, M. Fröhler: Binding of H-spiperone to human lymphocytes: a biological marker in schizophrenia? Accepted by Psychiatry Research 1984
A. Carlsson, W. Kehr, M. Linquist: Receptor mediated control of dopamine- synthesis. In: Neuropsychopharmacology. Ed.: J. R. Boissier, H. Hippius, P. Pichot. American Elsevier Publ Comp Inc New York, pp 468–471 (1975)
K. Conrad, W. Scheid, H. J. Weitbrecht: Die beginnende Schizophrenie. Versuch einer Gestaltanalyse des Wahns. Sammlung psychiatrischer und neurologischer Einzeldarstellungen. Georg Thieme Verlag, Stuttart (1958).
I. Creese, D.R. Burt, S.H. Snyder: Dopamine receptor binding: Differentiation of agonist and antagonist states with H-dopamine and Haloperidol. Life Science 17, 993–1002 (1975)
A. J. Cross, T. J. Crow, A. Longden, F. Owen, M. Poulter, G.J. Riley: Evidence for increased dopamine receptor sensitivity in post mortem brains from patients with schizophrenia. J Physiol 290:456 (1978)
T. J. Crow: Molecular pathology of schizophrenia: more than one disease process. Br Med J 6207:66–68 (1980)
T. Eibl-Eiblsfeld: Elternhaltung, psychophysiologische Erregung und Rückfallquote bei schizophrenen Patienten. Diss, vor der med. Fakultät der LMU München, 1983.
Groß : Presynaptic alpha-adrenergic neurones. Nauyn-Schmiedebergfs Arch Pharmacol Sppl 313:387 (1980)
Katschig : Sozialer Stress und psychische Krankheit. In: Fortschritte der Sozialpsychiatrie, Vol 5. Urban und Schwarzenberg, München (1978)
R. E. Kendell: Waht are our criteria for a diagnosis of schizophrenia? In: H.M. van Praag (ed.). On the origin of schizophrenic psychoses. E Evven Bohn BV, Amsterdam (1975)
CH. Lake, M. Ziegler, I. Kopin: Use of plasma norepinephrine for evaluation of sympathetic neuronal function in man. Life Sciences 18, 1315–1326 (1976)
Y. Lecrubier and P. Douillet. In: N. Matussek et al., Noradrenalin plasma level after sulpiride and other antidepressants during rest and ergomety. In: N. Matussek and M. Ackenheil (eds.): Special aspects of psychopharmacology. Possible clinical significance of recent biochemical and pharmacological findings with ortho-methoxy-benzamides. Expansiom Scientifique Française, Paris (1983).
S. Matthyse: Antipsychotic drug actions: a cue to the neuropathology of schizophrenia. Fed Proc, 200–205 (1973)
N. Matussek, M. Ackenheil, M. Herz: The dependence of the Clonidine growth hormone test on alcohol drinking habits and the menstrual cycle. (Accepted for publication by Psychoneuroendocrinology, 1984)
D. Naber, F. Müller-Spahn: Effects of long-term neuroleptic treatment on serum levels of prolactin, TSH, LH and norepinephine, alpha-adrenergic and dopaminergic receptor sensitivity. Relation to tardive dyskinesia, 1983.
D. Naber, C. Finkbeiner, H. Fischer, K. Zander, M. Ackenheil: Effect of long-term neuroleptic treatment on prolactin and norepinephrine levels in serum of chronic schizophrenics: Relations to psychopathology and extrapyramidal symptoms. Neuropsychobiology 6, 181–189 (1980)
D. Naber, M. Albus, F. Müller-Spahn, H. Bürke, D. Welter, M. Ackenheil, H. Hippius: ß-endorphin, Cortisol and prolactin in serum of schizophrenic patients during long-term neuroleptic treatment and after withdrawal. Psychopharm Bull 18, 224–226 (1982)
D. Naber und D. Pickar: Endorphins in CSF and plasma of psychiatric patients. Arzneim Forsch 32, 877–878 (1982)
D. Naber, U. Münch, J. Wissmann, R. Grosse, R. Ritt, D. Welter: Naloxone treatment for 5 days ineffective in schizophrenia. Neuroendocrine actions of the opiate antagonist. Acta Psychiat Scand 67, 265–271 (1983)
G. N. Pandey, D. L. Garver, C. Tamminga, S. Ericksen, S.J. Ali, 3.M. Davis: Postsynaptic supersensitivity in schizophrenia. Am J Psychiat 134:518–522 (1977).
J. Rotrosen, B. Angrist, S. Gershon, J. Paquin, L. Branchey, M. Oleshansky, F. Halpern, E. J. Sachar: Neuroendocrine effects of apomorphine: characterization of response pattern and application to schizophrenia research. Brit J Psychiat 135, 444–456 (1979)
N. Tarrier, C.E. Vaughn, M.H. Lader, J.P. Leff: Bodily reactions to people and events in schizophrenics. Archives of General Psychiatry, 36:311–315 (1979)
K. J. Zander, B. Fischer, R. Zimmer, M. Ackenheil: Long-term neuroleptic treatment of chronic schizophrenic patients: Clinical and biochemical effects of withdrawal. Psychopharmacology 73:43–47 (1981). (This publication will be published more detailed in “Der Nervenarzt” (1984).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1985 Springer Science+Business Media New York
About this chapter
Cite this chapter
Hippius, H., Ackenheil, M. (1985). Today’s Problems and Results of Biological Research in Schizophrenia. In: Pichot, P., Berner, P., Wolf, R., Thau, K. (eds) Biological Psychiatry, Higher Nervous Activity. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-8329-1_4
Download citation
DOI: https://doi.org/10.1007/978-1-4684-8329-1_4
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4684-8331-4
Online ISBN: 978-1-4684-8329-1
eBook Packages: Springer Book Archive